Abciximab - Apixaban - Bivalirudin - Coumadin - Dabigatran - Deltaparin - Dicoumarol - Edoxaban - Eptifibatide - Fondaparinux - Fraxiparin - Heparin - Hirudin - Idraparinux - LMWH - Reviparin - Rivaroxaban - Tirofiban - UFH - Wafarin - Warfarin - Ximelagatran
all type of patients 89 trials
unstable angina 1 trials
patients managed with an early invasive strategy 2 trials
PCI sub group 3 trials
patients with scheduled percutaneous coronary intervention 0 trials
patients with a recent ACS 6 trials
all type of patients 36 trials
patients with scheduled percutaneous coronary intervention 0 trials
patients ineligible for warfarin 2 trials
primary prevention of thromboembolic events 47 trials
secondary prevention of thromboembolic events 7 trials
secondary prevention 0 trials
patienst at high risk 0 trials
all type of patients 0 trials
diabetic patients 0 trials
primary prevention 0 trials
patient without history of atherosclerotic disease 0 trials
patients hospitalized for heart failure 1 trials
all type of patients 9 trials
patients with high residual platelet activity on clopidogrel 1 trials
PCI with stent placement 23 trials
MI patients undergoing primary PCI 2 trials
all type of patients 62 trials
after revascularisation 13 trials
all type of patients 7 trials
all type of patients 1 trials
all type of patients 1 trials
all type of patients 22 trials
all type of patient 14 trials
all type of patients 28 trials
antiplatelet therapy after stent placement (BMS) 0 trials
antiplatelet therapy after stent placement (DES) 0 trials
superficial thrombophlebitis of the leg 40 trials
general surgery 135 trials
urologic surgery 8 trials
gynaecological surgery 6 trials
oncolgical surgery 0 trials
abdominal surgery 32 trials
neurosurgery 4 trials
arthroscopy 7 trials
immobilisation by cast 0 trials
orthopedic surgery 160 trials
elective major knee surgery 18 trials
elective hip replacement 48 trials
hip Fracture 7 trials
patients with cancer 0 trials
patients with immobilization of the lower extremities 7 trials
patients with myocardial infarction 8 trials
medical patients 28 trials
secondary prevention - 2 23 trials
all type of patients 71 trials
patients with cancer 12 trials
secondary prevention of VTE 16 trials